Longer Patents for Lower Imitation Barriers: The 1984 Drug Act
dc.contributor.author | John Vernon | |
dc.date.accessioned | 2010-03-09T15:23:58Z | |
dc.date.available | 2010-03-09T15:23:58Z | |
dc.date.issued | 1986 | |
dc.description.abstract | In this paper we analyze its likely impacts on competition in the pharmaceutical industry, the incentives for innovation, and general consumer welfare. | |
dc.format.extent | 553678 bytes | |
dc.format.mimetype | application/pdf | |
dc.identifier.uri | ||
dc.language.iso | en_US | |
dc.publisher | American Economic Review | |
dc.subject | 1984 Drug Act | |
dc.subject | Imitation barriers | |
dc.subject | Impact of ANDAs | |
dc.subject | Longer patents | |
dc.title | Longer Patents for Lower Imitation Barriers: The 1984 Drug Act | |
dc.type | Journal article |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Vernon_longer_patents_for_lower_imitation_barriers.pdf
- Size:
- 540.7 KB
- Format:
- Adobe Portable Document Format